Early feasibility studies on climate-friendly albuterol inhaler completed

FHS
May 11, 2024
12:25 pm

DevPro Biopharma and Bespak have announced the completion of early feasibility studies on DP007, a new formulation of albuterol in a pressurized metered dose inhaler (pMDI) which shows comparable performance to Ventolin® HFA but with a significant reduction in greenhouse gas emissions.

Stethoscopes of the Future; GOP Fentanyl Misinfo; Egg Cracking Trend Conundrum

The following contains links to social media websites including X, TikTok, Instagram, Facebook, and LinkedIn. The future is here! @Dr_amoytheemd went viral this week for

August 25, 2023

AARP, in amicus brief, argues that CMS negotiating drug prices is in the public interest

The AARP on Friday filed an amicus brief asking a judge to uphold the Inflation Reduction Act, arguing that stopping the drug price negotiation program

August 19, 2023

Augmedix Integrates Google Cloud AI to Boost Medical Documentation

What You Should Know: – Augmedix, a leader in ambient medical documentation, is partnering with Google Cloud to integrate MedLM, a new healthcare-focused generative AI

December 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.